Related Experiment Video

Updated: Sep 11, 2025

Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model
08:53

Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model

Published on: January 1, 2017

9.3K

Identification of a novel TGFB1 variant in a patient with Camurati-Engelmann disease responsive to alendronate

Neelam Hassan1,2, Celia L Gregson1, Michael Oldridge3

  • 1Musculoskeletal Research Unit, University of Bristol, Bristol, UK.

Rheumatology (Oxford, England)
|August 14, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.3K
A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
07:00

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

Published on: April 1, 2019

10.1K

Related Experiment Videos

Last Updated: Sep 11, 2025

Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model
08:53

Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model

Published on: January 1, 2017

9.3K
An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.3K
A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
07:00

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

Published on: April 1, 2019

10.1K

Related Concept Videos

Immunoglobulin-like Cell Adhesion Molecules01:31

Immunoglobulin-like Cell Adhesion Molecules

3.4K
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
3.4K

Articles linked to this work by shared authors, journal, and citation graph.

The clinical and molecular spectrum of AGO2-associated Lessel-Kreienkamp neurodevelopmental syndrome.

Genome medicine·2026

Randomised controlled trial assessing the efficacy of balance acceptance and commitment therapy (ACT) for post-COVID syndrome: a study protocol.

BMJ open·2026

Understanding factors that impact patient access and engagement with biomedical and traditional care for hip fractures in The Gambia: An ethnographic study using a social ecological model.

PLOS global public health·2026

Multiscale analysis and functional validation of the cellular and genetic determinants of skeletal disease.

Nature genetics·2026

Hypertension and diabetes prevalence, associated factors, care cascade, and quality of life in older adults: A cross-sectional population-based study in The Gambia, South Africa, and Zimbabwe.

PLoS medicine·2026

Hospital costs attributable to further fracture, reoperation, and death during the first year following hip fracture in England : a nationwide cohort study.

The bone & joint journal·2026

Dysregulation of macrophage colony stimulating factor in Paget's disease of bone.

Rheumatology (Oxford, England)·2026

Validity of the 2023 ACR/EULAR APS classification criteria to pediatric primary APS: inputs from a systematic literature review.

Rheumatology (Oxford, England)·2026

Deep clinical renal response in lupus nephritis treated with belimumab: a real-world cohort study.

Rheumatology (Oxford, England)·2026

Contemporary issues relating to calcium pyrophosphate deposition disease.

Rheumatology (Oxford, England)·2026

Reasons-stratified treatment retention after JAK inhibitor discontinuation in rheumatoid arthritis: the ANSWER cohort study.

Rheumatology (Oxford, England)·2026

Distinct trajectories of disease severity progression in juvenile systemic sclerosis.

Rheumatology (Oxford, England)·2026

Artificial intelligence for ultrasound-based differentiation of soft tissue liposarcoma from benign masses.

Frontiers in medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us